Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Peptides CalculatorPeptides Calculator
Research Database

Peptide Library

Explore detailed profiles, dosing data, and mechanismsfor 100+ research compounds.

77 compounds20 pages

Research Use Only

All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.

Vial
5% RU-58841
Topical Non-Steroidal Anti-Androgen
View

RU-58841 is a non-steroidal anti-androgen developed for topical use, known for its ability to inhibit androgen receptors in hair follicles.

Half-life

Around 5 hours (topical)

Delivery

Topical

Dosage

—

Mechanism

Blocks dihydrotestosterone (DHT) from binding to androgen receptors in scalp follicles, reducing miniaturization of hair follicles.

Reduces hair lossBlocks DHT at receptor levelTopical application minimizes systemic effects
Full details→
HL: Around 5 hours (topical)Topical
Vial
5-Amino-1MQ
Nicotinamide N-methyltransferase Inhibitor
View

5-Amino-1MQ is a potent and selective small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that methylates nicotinamide to 1-methylnicotinamide, thereby modulating NAD⁺ metabolism and influencing energy expenditure and adiposity.

Half-life

Not well characterized

Delivery

Oral

Dosage

—

Mechanism

Binds to the active site of NNMT, preventing methylation of nicotinamide, which leads to increased intracellular NAD⁺ levels, enhanced mitochondrial function, and reduced lipogenesis.

Increased NAD⁺ levelsEnhanced mitochondrial functionReduced adiposity in diet-induced obesity modelsImproved glucose tolerance
Full details→
HL: Not well characterizedOral
Vial
9 Methyl β Carboline
Dopaminergic Nootropic Compound
View

9-Me-BC (9-Methyl-β-carboline) is a nootropic compound with neuroprotective and dopaminergic properties, promoting the growth and survival of dopaminergic neurons.

Half-life

12–16 hours (estimated)

Delivery

Oral or sublingual

Dosage

—

Mechanism

Promotes dopaminergic neuron differentiation and mitochondrial function, enhancing dopamine signaling and brain plasticity.

Supports dopamine productionEnhances motivation and moodPromotes neurogenesisNeuroprotection against oxidative stress
Full details→
HL: 12–16 hours (estimated)Oral or sublingual
Vial
ACE-031
Soluble Activin Type IIB Receptor–Fc Fusion (Myostatin/Activin Ligand Trap)
View

ACE-031 (ActRIIB-Fc Ligand Trap) is a recombinant fusion protein consisting of the extracellular domain of activin receptor type IIB (ActRIIB) linked to an IgG1 Fc fragment. It serves as a decoy receptor that binds myostatin (GDF8) and related ligands (e.g., activins), thereby reducing SMAD2/3 signaling to promote muscle and bone anabolism in research settings.

Half-life

Approximately 10–15 days (human PK, single-dose SC)

Delivery

Subcutaneous injection; historical clinical protocols dosed every 2–4 weeks.

Dosage

—

Mechanism

Ligand trap that sequesters myostatin and select activins from ActRIIA/B receptors, attenuating TGF-β/SMAD2/3 signaling; results include increased muscle protein synthesis/hypertrophy and bone accrual.

Increases lean body mass and muscle volume in human and animal studiesMay improve functional measures (e.g., 6-minute walk trends in DMD studies)Associated increases in bone mineral density in some models
Full details→
HL: Approximately 10–15 days (human PK, single-dose SC)Subcutaneous injection; historical clinical protocols dosed every 2–4 weeks.

Showing 1–4 of 77